Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Si-Bone (SIBN) Total Non-Current Liabilities (2017 - 2025)

Historic Total Non-Current Liabilities for Si-Bone (SIBN) over the last 9 years, with Q3 2025 value amounting to $62.1 million.

  • Si-Bone's Total Non-Current Liabilities rose 21.93% to $62.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $62.1 million, marking a year-over-year increase of 21.93%. This contributed to the annual value of $63.5 million for FY2024, which is 398.32% up from last year.
  • Per Si-Bone's latest filing, its Total Non-Current Liabilities stood at $62.1 million for Q3 2025, which was up 21.93% from $60.6 million recorded in Q2 2025.
  • Over the past 5 years, Si-Bone's Total Non-Current Liabilities peaked at $63.5 million during Q4 2024, and registered a low of $49.5 million during Q3 2021.
  • For the 5-year period, Si-Bone's Total Non-Current Liabilities averaged around $57.4 million, with its median value being $57.3 million (2023).
  • Its Total Non-Current Liabilities has fluctuated over the past 5 years, first tumbled by 332.69% in 2021, then soared by 1196.3% in 2022.
  • Quarter analysis of 5 years shows Si-Bone's Total Non-Current Liabilities stood at $56.0 million in 2021, then increased by 5.7% to $59.2 million in 2022, then rose by 3.06% to $61.0 million in 2023, then rose by 3.98% to $63.5 million in 2024, then fell by 2.07% to $62.1 million in 2025.
  • Its Total Non-Current Liabilities stands at $62.1 million for Q3 2025, versus $60.6 million for Q2 2025 and $60.0 million for Q1 2025.